tiprankstipranks
Advertisement
Advertisement

HK:0874 Stock Latest News

Baiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease
Company AnnouncementsBaiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease
8d ago
Guangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
PremiumCompany Announcements
Guangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
21d ago
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
PremiumCompany Announcements
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
2M ago
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
PremiumCompany Announcements
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
2M ago
Guangzhou Baiyunshan Sets March 2026 Board Meeting for 2025 Results
PremiumCompany Announcements
Guangzhou Baiyunshan Sets March 2026 Board Meeting for 2025 Results
2M ago
Guangzhou Baiyunshan Announces Vice Chair Resignation and Change of Authorised Representative
PremiumCompany AnnouncementsGuangzhou Baiyunshan Announces Vice Chair Resignation and Change of Authorised Representative
2M ago
Guangzhou Baiyunshan Sets Out Board Lineup and Committee Roles
Premium
Company Announcements
Guangzhou Baiyunshan Sets Out Board Lineup and Committee Roles
2M ago
Guangzhou Baiyunshan Finalises Partnership Agreement for GP Liwan Fund
Premium
Company Announcements
Guangzhou Baiyunshan Finalises Partnership Agreement for GP Liwan Fund
4M ago
Baiyunshan Pharma Clears All Resolutions at Third Extraordinary General Meeting of 2025
PremiumCompany Announcements
Baiyunshan Pharma Clears All Resolutions at Third Extraordinary General Meeting of 2025
4M ago
Baiyunshan Pharma Subsidiary Finalises GP Guangkai Fund Deal, Liwan Fund Agreement Pending
PremiumCompany Announcements
Baiyunshan Pharma Subsidiary Finalises GP Guangkai Fund Deal, Liwan Fund Agreement Pending
4M ago
Guangzhou Baiyunshan Subsidiary Secures Approval for New Rabies Vaccine
PremiumCompany Announcements
Guangzhou Baiyunshan Subsidiary Secures Approval for New Rabies Vaccine
4M ago
Baiyunshan Pharma Unit to Commit Nearly RMB200 Million to Two New Venture Funds in Connected Deals
PremiumCompany Announcements
Baiyunshan Pharma Unit to Commit Nearly RMB200 Million to Two New Venture Funds in Connected Deals
4M ago
Baiyunshan Renews Connected Transactions Framework With Controlling Shareholder for 2026
PremiumCompany AnnouncementsBaiyunshan Renews Connected Transactions Framework With Controlling Shareholder for 2026
4M ago
Guangzhou Baiyunshan Acquires 100% Equity in Strategic Expansion Move
Premium
Company Announcements
Guangzhou Baiyunshan Acquires 100% Equity in Strategic Expansion Move
5M ago
Guangzhou Baiyunshan Pharmaceutical to Hold 2025 Extraordinary General Meeting
Premium
Company Announcements
Guangzhou Baiyunshan Pharmaceutical to Hold 2025 Extraordinary General Meeting
5M ago
Guangzhou Baiyunshan Plans Asset-Backed Securitization to Boost Liquidity
PremiumCompany Announcements
Guangzhou Baiyunshan Plans Asset-Backed Securitization to Boost Liquidity
5M ago
Guangzhou Baiyunshan’s GP Corp. Engages in Disclosable Transaction with Industrial Securities
PremiumCompany Announcements
Guangzhou Baiyunshan’s GP Corp. Engages in Disclosable Transaction with Industrial Securities
5M ago
Guangzhou Baiyunshan Subsidiary Secures Land Reserve Compensation Agreement
PremiumCompany Announcements
Guangzhou Baiyunshan Subsidiary Secures Land Reserve Compensation Agreement
5M ago
Guangzhou Baiyunshan Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Guangzhou Baiyunshan Reports Strong Q3 2025 Growth
6M ago
Guangzhou Baiyunshan Reports Strong Q3 2025 Profit Growth Amid Cash Flow Challenges
PremiumCompany AnnouncementsGuangzhou Baiyunshan Reports Strong Q3 2025 Profit Growth Amid Cash Flow Challenges
6M ago
Guangzhou Baiyunshan Pharmaceutical Enhances Governance with Revised Committee Rules
Premium
Company Announcements
Guangzhou Baiyunshan Pharmaceutical Enhances Governance with Revised Committee Rules
6M ago
Guangzhou Baiyunshan Pharmaceutical Embraces Board Diversity for Sustainable Growth
Premium
Company Announcements
Guangzhou Baiyunshan Pharmaceutical Embraces Board Diversity for Sustainable Growth
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >